MK-2420 SAD Study
This clinical trial is about a new medicine, known as MK-2420, which is being investigated for rheumatoid arthritis. This is a very early study, called a Phase 1 trial, meaning it's the very first time this particular medicine is being tested in humans. The main goal is to see if the medicine is safe and to understand how the body processes it. They will be looking at how much medicine is needed and checking for any side effects. To take part in this specific study, volunteers must be adult men, aged 18 or older. It's an important step in developing new treatments, but it's important to remember this is just the beginning of understanding this new medicine.
At a glance
What is this study about?
This study is about a new medicine called MK-2420, which scientists hope might help people with rheumatoid arthritis. Rheumatoid arthritis is a condition where your body's immune system mistakenly attacks your joints, causing pain, swelling, and stiffness. Finding new ways to treat this condition is very important.
This particular study is a very early one, known as a 'Phase 1' study. Think of it like the first time a new car goes on the road after being built in the factory. The main aim isn't to see if the car wins a race, but to check that it handles safely and that all its basic parts are working correctly. Similarly, in this trial, the doctors want to check the safety of MK-2420 and understand how it behaves in the human body – for example, how much of it gets into the blood and how long it stays there.
Because it's the first time this medicine is being given to people, these types of studies usually involve a small number of healthy volunteers, or sometimes people with the condition itself, to carefully monitor what happens. The information gathered from this study will be crucial for deciding if MK-2420 is safe enough to be tested in larger groups of people in the future.
Key takeaways
- This is an early study of a new medicine for rheumatoid arthritis.
- It's the first time this medicine is being given to humans.
- The main aim is to check its safety and how the body processes it.
- Only men aged 18 and over can participate.
- Participation involves close monitoring after receiving the medicine.
- You can withdraw from the study at any time.
Who may be eligible?
To be considered for this study, you must be an adult. Specifically, you need to be at least 18 years old – there's no upper age limit, so older adults can also take part.
Another important requirement is that this study is only for men. Women cannot take part in this particular trial.
Remember, these are just the basic conditions. If you meet these, there will be further health checks and discussions with the study team to see if the study is right for you and if you meet all other specific health requirements.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you male?
- Are you able to attend study visits as required?
- Do you understand that this is an early-stage study and not a treatment?
What does participation involve?
If you decide to take part in this study, you would first have a screening visit. This visit is to check your health thoroughly to make sure taking part is safe for you. This would involve a medical history review, a physical examination, and blood and urine tests.
After screening, if you are suitable, you would come to the study clinic for the medicine administration. You would receive a single dose of the study medicine, MK-2420. Following this, you would stay at the clinic for a period, where nurses and doctors would closely monitor you. They would regularly take blood samples to measure how the medicine is processed by your body and check your vital signs (like heart rate and blood pressure) and any side effects.
The total duration of your active participation, including your stay at the clinic and any follow-up visits, would be explained in detail by the study team. You would also have a final check-up after the main part of the study to ensure your health is still good.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is rheumatoid arthritis?
Rheumatoid arthritis is a condition where your body's immune system mistakenly attacks your joints, causing pain, swelling, and stiffness, mainly in the hands and feet.
What does 'Phase 1' mean for a clinical trial?
Phase 1 means it's the very first time a new medicine is being given to people. The main goals are to check if it's safe and how the body handles it, not to treat the illness yet.
Will this medicine cure my rheumatoid arthritis?
No, this is a very early safety study. Its purpose is not to treat or cure rheumatoid arthritis at this stage, but to gather basic information about the new medicine.
Will I get paid for taking part?
Some studies offer payment for your time and inconvenience, but this varies. You should ask the study team directly if financial compensation is offered for this trial.
What happens if I change my mind?
You are free to leave the study at any time, for any reason, without it affecting your medical care. This is your right as a participant.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.